ArkBio Begins Phase II Trial of AK0610 for RSV Prevention
Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”) today announced the initiation of a Phase II clinical study of AK0610, a fully human monoclonal antibody designed to prevent...
Category : Healthcare and Pharmaceutical
Alys Pharma Doses First Subject in Phase 1/1b Trial of ALY-301
Differentiated profile of ALY-301 designed to enable chronic dosing in mast cell dependent diseases while avoiding the safety limitations of conventional c-Kit inhibitors Multicenter Phase...
Vesper Bio Reports Positive Phase Ib/IIa Results for VES001
Phase Ib/IIa study found VES001, the first oral therapy being tested in FTD, led to >95% mean increase in progranulin levels in CSF, compared to baseline...
Kexing Biopharm Showcases Global Strategy at CPHI Frankfurt 2025
From October 28th to 30th, Kexing Biopharm participated in CPHI Frankfurt 2025, one of the world’s most influential pharmaceutical exhibitions, presenting its key product portfolio and...
Elevaris Medical Devices Appoints New Chief Engineering Officer
Elevaris Medical Devices, a Contract Development and Manufacturing Organization for industry-leading multi-national healthcare companies, announced the appointment of its new Chief Engineering and Operations Officer,...
Surmodics Reports Sex-Specific PROWL Study Results with Pounce™
Analysis of 160 patients with acute, subacute, or chronic symptoms of thrombotic limb ischemia receiving thromboemboli removal treatment with the Pounce™ Thrombectomy Platform demonstrated high...
Insulet Promotes Workplace Inclusion for People with Diabetes
Insulet launches campaign inspired by the International Diabetes Federation’s focus on diabetes, well-being, and the workplace “The Day Diabetes Showed Up to Work” campaign recognizes...
ProImmune Introduces ProVE® SL Monomers for T Cell Research
ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers. The novel...
KalVista to Share EKTERLY® Data at Allergy & Immunology 2025
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of one abstract for late-breaking oral presentation and three for poster presentation at the American College...
PanGIA Biotech to Present 4 Abstracts at ISLB 2025
PanGIA’s scalable technology demonstrates ability to detect disease-specific molecular patterns across multiple clinical biofluids PanGIA Biotech announced today four of its abstracts were accepted for presentation...
Lantern Pharma to Present AI Cancer Drug Platforms at UNT
Lantern Pharma Inc. (NASDAQ: LTRN)— Lantern today announced it will present two commercially deployed AI research platforms at the inaugural AI for Biology and Medicine...
Canadian Tech Provides Clearer Hospital Bedside Imaging
OBIO® supports implementation of new advanced X-ray machine at UHN Each year, more than 20 million diagnostic X-ray procedures are performed in Canada according to...
Pinetree Therapeutics Raises $47M to Advance Protein Degraders
Pinetree Therapeutics, a preclinical-stage biotechnology company pioneering targeted protein degraders for drug-resistant cancers, announced the successful closing of an oversubscribed $47 million Series B financing....
OMRON Healthcare Wins Best in Class at 2025 Digital Health Awards
Expert judges determining the best of the best in healthcare innovation recognized OMRON Healthcare for its blood pressure monitors with AI-powered AFib detection Judges in the...
MGI Tech Licenses CoolMPS™ Sequencing Tech to Swiss Rockets AG
MGI Tech Co., Ltd. (“MGI”), a company dedicated to developing core tools and technologies that drive innovation in life sciences, today announced entering into an...